{"transactions":[{"id":1458476,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEACLA and JAPAC"}}],"security":"Common Stock","published_at":"2024-07-08T22:26:44.000Z","date":"2024-07-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":82,"price":92.32,"value":7570.24,"ownership":{"direct":true},"balance_after":184685.8054,"source":{"system":"sec-edgar","filing":"0001225208-24-007359","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824007359/doc4.xml","form_type":"4"}},{"id":1519594,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEACLA and JAPAC"}}],"security":"Common Stock","published_at":"2024-05-13T21:46:48.000Z","date":"2024-05-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":21,"price":86.72,"value":1821.12,"ownership":{"direct":true},"balance_after":184767.8055,"source":{"system":"sec-edgar","filing":"0001225208-24-005982","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005982/doc4.xml","form_type":"4"}},{"id":1522394,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEACLA and JAPAC"}}],"security":"Performance Rights","published_at":"2024-05-09T23:39:16.000Z","date":"2024-05-07","kind":"grant","planned":false,"acquired":true,"shares":7125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock unites granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2027. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock unites granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2027. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."}],"balance_after":7125,"derivative":{"exercise_date":"2027-05-07","underlying":"Common Stock","underlying_shares":7125},"source":{"system":"sec-edgar","filing":"0001225208-24-005888","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005888/doc4.xml","form_type":"4"}},{"id":1522393,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEACLA and JAPAC"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2024-05-09T23:39:16.000Z","date":"2024-05-07","kind":"grant","planned":false,"acquired":true,"shares":42200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one month after the grant date in 36 approximately equal monthly installments."}],"balance_after":42200,"derivative":{"exercise_price":85.84,"exercise_date":"2025-05-07","expiration_date":"2031-05-06","underlying":"Common Stock","underlying_shares":42200},"source":{"system":"sec-edgar","filing":"0001225208-24-005888","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005888/doc4.xml","form_type":"4"}},{"id":1522392,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEACLA and JAPAC"}}],"security":"Common Stock","published_at":"2024-05-09T23:39:16.000Z","date":"2024-05-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":46,"price":85.09,"value":3914.14,"ownership":{"direct":true},"balance_after":184788.8055,"source":{"system":"sec-edgar","filing":"0001225208-24-005888","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005888/doc4.xml","form_type":"4"}},{"id":1522391,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEACLA and JAPAC"}}],"security":"Common Stock","published_at":"2024-05-09T23:39:16.000Z","date":"2024-05-07","kind":"grant","planned":false,"acquired":true,"shares":7125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":184834.8055,"source":{"system":"sec-edgar","filing":"0001225208-24-005888","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005888/doc4.xml","form_type":"4"}},{"id":1526674,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEACLA and JAPAC"}}],"security":"Performance Rights","published_at":"2024-05-06T23:18:04.000Z","date":"2024-05-04","kind":"exercise","planned":false,"acquired":false,"shares":4157,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On May 4, 2021, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 1, 2024, the Compensation and Governance Committee of the Board of Directors determined that 117.11% of the target number of shares would vest as of May 4, 2024, and the actual number of shares vested are reflected on this Form 4."}],"balance_after":0,"derivative":{"exercise_date":"2024-05-04","expiration_date":"2028-05-03","underlying":"Common Stock","underlying_shares":4157},"source":{"system":"sec-edgar","filing":"0001225208-24-005702","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005702/doc4.xml","form_type":"4"}},{"id":1526673,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEACLA and JAPAC"}}],"security":"Common Stock","published_at":"2024-05-06T23:18:04.000Z","date":"2024-05-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":259,"price":85.25,"value":22079.75,"ownership":{"direct":true},"balance_after":177709.8055,"source":{"system":"sec-edgar","filing":"0001225208-24-005702","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005702/doc4.xml","form_type":"4"}},{"id":1526672,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEACLA and JAPAC"}}],"security":"Common Stock","published_at":"2024-05-06T23:18:04.000Z","date":"2024-05-04","kind":"exercise","planned":false,"acquired":true,"shares":4157,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 4, 2021, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 1, 2024, the Compensation and Governance Committee of the Board of Directors determined that 117.11% of the target number of shares would vest as of May 4, 2024, and the actual number of shares vested are reflected on this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 4, 2021, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 1, 2024, the Compensation and Governance Committee of the Board of Directors determined that 117.11% of the target number of shares would vest as of May 4, 2024, and the actual number of shares vested are reflected on this Form 4."}],"balance_after":177968.8055,"source":{"system":"sec-edgar","filing":"0001225208-24-005702","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005702/doc4.xml","form_type":"4"}},{"id":1526671,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEACLA and JAPAC"}}],"security":"Common Stock","published_at":"2024-05-06T23:18:04.000Z","date":"2024-05-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":37,"price":85.06,"value":3147.22,"ownership":{"direct":true},"balance_after":173811.8055,"source":{"system":"sec-edgar","filing":"0001225208-24-005702","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005702/doc4.xml","form_type":"4"}},{"id":1532293,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEACLA and JAPAC"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2024-05-01T21:17:33.000Z","date":"2024-05-01","kind":"exercise","planned":true,"acquired":false,"shares":14400,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":36.75,"exercise_date":"2018-05-11","expiration_date":"2024-05-10","underlying":"Common Stock","underlying_shares":14400},"source":{"system":"sec-edgar","filing":"0001225208-24-005437","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005437/doc4.xml","form_type":"4"}},{"id":1532292,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEACLA and JAPAC"}}],"security":"Common Stock","published_at":"2024-05-01T21:17:33.000Z","date":"2024-05-01","kind":"sale","planned":true,"acquired":false,"shares":12240,"price":84.1053,"value":1029448.872,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $83.740 to $84.725. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":173848.8055,"source":{"system":"sec-edgar","filing":"0001225208-24-005437","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005437/doc4.xml","form_type":"4"}},{"id":1532291,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEACLA and JAPAC"}}],"security":"Common Stock","published_at":"2024-05-01T21:17:33.000Z","date":"2024-05-01","kind":"sale","planned":true,"acquired":false,"shares":2160,"price":84.8325,"value":183238.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $84.750 to $84.930. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":186088.8055,"source":{"system":"sec-edgar","filing":"0001225208-24-005437","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005437/doc4.xml","form_type":"4"}},{"id":1532290,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEACLA and JAPAC"}}],"security":"Common Stock","published_at":"2024-05-01T21:17:33.000Z","date":"2024-05-01","kind":"exercise","planned":true,"acquired":true,"shares":14400,"price":36.75,"value":529200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2023."}],"balance_after":188248.8055,"source":{"system":"sec-edgar","filing":"0001225208-24-005437","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005437/doc4.xml","form_type":"4"}},{"id":1546113,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEACLA"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2024-04-08T21:10:58.000Z","date":"2024-04-08","kind":"exercise","planned":true,"acquired":false,"shares":14400,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":14400,"derivative":{"exercise_price":36.75,"exercise_date":"2018-05-11","expiration_date":"2024-05-10","underlying":"Common Stock","underlying_shares":14400},"source":{"system":"sec-edgar","filing":"0001225208-24-005005","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005005/doc4.xml","form_type":"4"}},{"id":1546112,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEACLA"}}],"security":"Common Stock","published_at":"2024-04-08T21:10:58.000Z","date":"2024-04-08","kind":"sale","planned":true,"acquired":false,"shares":14293,"price":92.322,"value":1319558.346,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $91.65 to $92.61. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":173848.8055,"source":{"system":"sec-edgar","filing":"0001225208-24-005005","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005005/doc4.xml","form_type":"4"}},{"id":1546111,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEACLA"}}],"security":"Common Stock","published_at":"2024-04-08T21:10:58.000Z","date":"2024-04-08","kind":"sale","planned":true,"acquired":false,"shares":107,"price":92.65,"value":9913.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2023."}],"balance_after":188141.8055,"source":{"system":"sec-edgar","filing":"0001225208-24-005005","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005005/doc4.xml","form_type":"4"}},{"id":1546110,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEACLA"}}],"security":"Common Stock","published_at":"2024-04-08T21:10:58.000Z","date":"2024-04-08","kind":"exercise","planned":true,"acquired":true,"shares":14400,"price":36.75,"value":529200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2023."}],"balance_after":188248.8055,"source":{"system":"sec-edgar","filing":"0001225208-24-005005","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005005/doc4.xml","form_type":"4"}},{"id":1584897,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEACLA and JAPAC"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2024-03-11T22:00:57.000Z","date":"2024-03-11","kind":"exercise","planned":true,"acquired":false,"shares":14400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2023."}],"balance_after":28800,"derivative":{"exercise_price":36.75,"exercise_date":"2018-05-11","expiration_date":"2024-05-10","underlying":"Common Stock","underlying_shares":14400},"source":{"system":"sec-edgar","filing":"0001225208-24-004035","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824004035/doc4.xml","form_type":"4"}},{"id":1584896,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEACLA and JAPAC"}}],"security":"Common Stock","published_at":"2024-03-11T22:00:57.000Z","date":"2024-03-11","kind":"sale","planned":true,"acquired":false,"shares":14400,"price":91.677,"value":1320148.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $91.4500 to $92.0075. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":173583.7785,"source":{"system":"sec-edgar","filing":"0001225208-24-004035","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824004035/doc4.xml","form_type":"4"}},{"id":1584895,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEACLA and JAPAC"}}],"security":"Common Stock","published_at":"2024-03-11T22:00:57.000Z","date":"2024-03-11","kind":"exercise","planned":true,"acquired":true,"shares":14400,"price":36.75,"value":529200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2023."}],"balance_after":187983.7785,"source":{"system":"sec-edgar","filing":"0001225208-24-004035","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824004035/doc4.xml","form_type":"4"}},{"id":1833188,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEACLA and JAPAC"}}],"security":"Common Stock","published_at":"2023-07-07T21:10:22.000Z","date":"2023-07-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":81,"price":90.46,"value":7327.26,"ownership":{"direct":true},"balance_after":173583.7785,"source":{"system":"sec-edgar","filing":"0001225208-23-007394","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823007394/doc4.xml","form_type":"4"}},{"id":1894039,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEACLA and JAPAC"}}],"security":"Performance Rights","published_at":"2023-05-15T22:25:54.000Z","date":"2023-05-11","kind":"grant","planned":false,"acquired":true,"shares":1975,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 11, 2023 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and scheduled to vest on May 11, 2026. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 11, 2023 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and scheduled to vest on May 11, 2026. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."}],"balance_after":1975,"derivative":{"exercise_date":"2026-05-11","underlying":"Common Stock","underlying_shares":1975},"source":{"system":"sec-edgar","filing":"0001225208-23-005917","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005917/doc4.xml","form_type":"4"}},{"id":1894038,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEACLA and JAPAC"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2023-05-15T22:25:54.000Z","date":"2023-05-11","kind":"grant","planned":false,"acquired":true,"shares":13300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on May 11, 2023 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one month after the grant date in 36 approximately equal monthly installments."}],"balance_after":13300,"derivative":{"exercise_price":88.78,"exercise_date":"2024-05-11","expiration_date":"2030-05-10","underlying":"Common Stock","underlying_shares":13300},"source":{"system":"sec-edgar","filing":"0001225208-23-005917","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005917/doc4.xml","form_type":"4"}},{"id":1894037,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEACLA and JAPAC"}}],"security":"Common Stock","published_at":"2023-05-15T22:25:54.000Z","date":"2023-05-11","kind":"grant","planned":false,"acquired":true,"shares":1575,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 11, 2023 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":173664.7785,"source":{"system":"sec-edgar","filing":"0001225208-23-005917","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005917/doc4.xml","form_type":"4"}},{"id":1899913,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEACLA and JAPAC"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2023-05-09T23:48:39.000Z","date":"2023-05-09","kind":"exercise","planned":true,"acquired":false,"shares":6640,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":35.1967,"exercise_date":"2017-05-12","expiration_date":"2023-05-11","underlying":"Common Stock","underlying_shares":6640},"source":{"system":"sec-edgar","filing":"0001225208-23-005617","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005617/doc4.xml","form_type":"4"}},{"id":1899912,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEACLA and JAPAC"}}],"security":"Performance Rights","published_at":"2023-05-09T23:48:39.000Z","date":"2023-05-07","kind":"exercise","planned":true,"acquired":false,"shares":3355,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On May 7, 2020, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 1, 2023, the Compensation Committee of the Board of Directors determined that 78.48% of the target number of shares would vest as of May 1, 2023, and the actual number of shares vested are reflected on this Form 4."}],"balance_after":920,"derivative":{"exercise_date":"2023-05-07","expiration_date":"2027-05-06","underlying":"Common Stock","underlying_shares":3355},"source":{"system":"sec-edgar","filing":"0001225208-23-005617","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005617/doc4.xml","form_type":"4"}},{"id":1899911,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEACLA and JAPAC"}}],"security":"Common Stock","published_at":"2023-05-09T23:48:39.000Z","date":"2023-05-09","kind":"sale","planned":true,"acquired":false,"shares":6640,"price":88.68,"value":588835.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 10, 2022."}],"balance_after":172089.7785,"source":{"system":"sec-edgar","filing":"0001225208-23-005617","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005617/doc4.xml","form_type":"4"}},{"id":1899910,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEACLA and JAPAC"}}],"security":"Common Stock","published_at":"2023-05-09T23:48:39.000Z","date":"2023-05-09","kind":"exercise","planned":true,"acquired":true,"shares":6640,"price":35.1967,"value":233706.088,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 10, 2022."}],"balance_after":178729.7785,"source":{"system":"sec-edgar","filing":"0001225208-23-005617","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005617/doc4.xml","form_type":"4"}},{"id":1899909,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEACLA and JAPAC"}}],"security":"Common Stock","published_at":"2023-05-09T23:48:39.000Z","date":"2023-05-08","kind":"tax_withholding","planned":true,"acquired":false,"shares":104,"price":88.74,"value":9228.96,"ownership":{"direct":true},"balance_after":172089.7785,"source":{"system":"sec-edgar","filing":"0001225208-23-005617","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005617/doc4.xml","form_type":"4"}},{"id":1899908,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEACLA and JAPAC"}}],"security":"Common Stock","published_at":"2023-05-09T23:48:39.000Z","date":"2023-05-07","kind":"tax_withholding","planned":true,"acquired":false,"shares":224,"price":88.74,"value":19877.76,"ownership":{"direct":true},"balance_after":172193.7785,"source":{"system":"sec-edgar","filing":"0001225208-23-005617","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005617/doc4.xml","form_type":"4"}},{"id":1899907,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEACLA and JAPAC"}}],"security":"Common Stock","published_at":"2023-05-09T23:48:39.000Z","date":"2023-05-07","kind":"exercise","planned":true,"acquired":true,"shares":3355,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 7, 2020, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 1, 2023, the Compensation Committee of the Board of Directors determined that 78.48% of the target number of shares would vest as of May 1, 2023, and the actual number of shares vested are reflected on this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 7, 2020, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 1, 2023, the Compensation Committee of the Board of Directors determined that 78.48% of the target number of shares would vest as of May 1, 2023, and the actual number of shares vested are reflected on this Form 4."}],"balance_after":172417.7785,"source":{"system":"sec-edgar","filing":"0001225208-23-005617","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005617/doc4.xml","form_type":"4"}},{"id":1904795,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEACLA and JAPAC"}}],"security":"Common Stock","published_at":"2023-05-05T01:48:45.000Z","date":"2023-05-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":38,"price":88.1,"value":3347.8,"ownership":{"direct":true},"balance_after":169062.7785,"source":{"system":"sec-edgar","filing":"0001225208-23-005433","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005433/doc4.xml","form_type":"4"}},{"id":1904794,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEACLA and JAPAC"}}],"security":"Common Stock","published_at":"2023-05-05T01:48:45.000Z","date":"2023-05-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":37,"price":87.81,"value":3248.97,"ownership":{"direct":true},"balance_after":169100.7785,"source":{"system":"sec-edgar","filing":"0001225208-23-005433","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005433/doc4.xml","form_type":"4"}},{"id":1924083,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEACLA and JAPAC"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2023-04-06T20:51:43.000Z","date":"2023-04-06","kind":"exercise","planned":true,"acquired":false,"shares":6640,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6640,"derivative":{"exercise_price":35.1967,"exercise_date":"2017-05-12","expiration_date":"2023-05-11","underlying":"Common Stock","underlying_shares":6640},"source":{"system":"sec-edgar","filing":"0001225208-23-004761","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823004761/doc4.xml","form_type":"4"}},{"id":1924082,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEACLA and JAPAC"}}],"security":"Common Stock","published_at":"2023-04-06T20:51:43.000Z","date":"2023-04-06","kind":"sale","planned":true,"acquired":false,"shares":6640,"price":83.0973,"value":551766.072,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 10, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $82.79 to $83.45 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":169137.7785,"source":{"system":"sec-edgar","filing":"0001225208-23-004761","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823004761/doc4.xml","form_type":"4"}},{"id":1924081,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEACLA and JAPAC"}}],"security":"Common Stock","published_at":"2023-04-06T20:51:43.000Z","date":"2023-04-06","kind":"exercise","planned":true,"acquired":true,"shares":6640,"price":35.1967,"value":233706.088,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 10, 2022."}],"balance_after":175777.7785,"source":{"system":"sec-edgar","filing":"0001225208-23-004761","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823004761/doc4.xml","form_type":"4"}},{"id":1964068,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEACLA and JAPAC"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2023-03-08T22:57:04.000Z","date":"2023-03-08","kind":"exercise","acquired":false,"shares":6640,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13280,"derivative":{"exercise_price":35.1967,"exercise_date":"2017-05-12","expiration_date":"2023-05-11","underlying":"Common Stock","underlying_shares":6640},"source":{"system":"sec-edgar","filing":"0001225208-23-003597","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823003597/doc4.xml","form_type":"4"}},{"id":1964067,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEACLA and JAPAC"}}],"security":"Common Stock","published_at":"2023-03-08T22:57:04.000Z","date":"2023-03-08","kind":"sale","acquired":false,"shares":6590,"price":76.9537,"value":507124.883,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 10, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $76.43 to $77.36 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":168874.8696,"source":{"system":"sec-edgar","filing":"0001225208-23-003597","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823003597/doc4.xml","form_type":"4"}},{"id":1964066,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEACLA and JAPAC"}}],"security":"Common Stock","published_at":"2023-03-08T22:57:04.000Z","date":"2023-03-08","kind":"sale","acquired":false,"shares":50,"price":77.43,"value":3871.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 10, 2022."}],"balance_after":175464.8696,"source":{"system":"sec-edgar","filing":"0001225208-23-003597","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823003597/doc4.xml","form_type":"4"}},{"id":1964065,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEACLA and JAPAC"}}],"security":"Common Stock","published_at":"2023-03-08T22:57:04.000Z","date":"2023-03-08","kind":"exercise","acquired":true,"shares":6640,"price":35.1967,"value":233706.088,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 10, 2022."}],"balance_after":175514.8696,"source":{"system":"sec-edgar","filing":"0001225208-23-003597","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823003597/doc4.xml","form_type":"4"}},{"id":2209320,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Performance Rights","published_at":"2022-07-12T00:04:52.000Z","date":"2022-07-07","kind":"grant","acquired":true,"shares":7625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted on July 7, 2022 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and scheduled to vest on July 7, 2025. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted on July 7, 2022 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and scheduled to vest on July 7, 2025. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."}],"balance_after":7625,"derivative":{"exercise_date":"2025-07-07","underlying":"Common Stock","underlying_shares":7625},"source":{"system":"sec-edgar","filing":"0001225208-22-008764","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822008764/doc4.xml","form_type":"4"}},{"id":2209319,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2022-07-12T00:04:52.000Z","date":"2022-07-07","kind":"grant","acquired":true,"shares":54500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on July 7, 2022 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one month after the grant date in 36 approximately equal monthly installments."}],"balance_after":54500,"derivative":{"exercise_price":98.43,"exercise_date":"2023-07-07","expiration_date":"2029-07-06","underlying":"Common Stock","underlying_shares":54500},"source":{"system":"sec-edgar","filing":"0001225208-22-008764","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822008764/doc4.xml","form_type":"4"}},{"id":2209318,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Common Stock","published_at":"2022-07-12T00:04:52.000Z","date":"2022-07-07","kind":"grant","acquired":true,"shares":6100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on July 7, 2022 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":168874.8696,"source":{"system":"sec-edgar","filing":"0001225208-22-008764","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822008764/doc4.xml","form_type":"4"}},{"id":2268867,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Common Stock","published_at":"2022-05-18T01:16:08.000Z","date":"2022-05-17","kind":"tax_withholding","acquired":false,"shares":143,"price":95.93,"value":13717.99,"ownership":{"direct":true},"balance_after":162756.3402,"source":{"system":"sec-edgar","filing":"0001225208-22-007136","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822007136/doc4.xml","form_type":"4"}},{"id":2276590,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2022-05-11T00:54:33.000Z","date":"2022-05-09","kind":"exercise","acquired":false,"shares":11560,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":21.76,"exercise_date":"2016-05-14","expiration_date":"2022-05-13","underlying":"Common Stock","underlying_shares":11560},"source":{"system":"sec-edgar","filing":"0001225208-22-006814","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822006814/doc4.xml","form_type":"4"}},{"id":2276589,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Performance Rights","published_at":"2022-05-11T00:54:33.000Z","date":"2022-05-08","kind":"exercise","acquired":false,"shares":8531,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On May 8, 2019, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 2, 2022, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 8, 2022, and the actual number of shares vested are reflected on this Form 4."}],"balance_after":0,"derivative":{"exercise_date":"2022-05-08","expiration_date":"2026-05-07","underlying":"Common Stock","underlying_shares":8531},"source":{"system":"sec-edgar","filing":"0001225208-22-006814","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822006814/doc4.xml","form_type":"4"}},{"id":2276588,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Common Stock","published_at":"2022-05-11T00:54:33.000Z","date":"2022-05-09","kind":"sale","acquired":false,"shares":11560,"price":98.2447,"value":1135708.732,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 29, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $97.95 to $98.66. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":162899.3402,"source":{"system":"sec-edgar","filing":"0001225208-22-006814","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822006814/doc4.xml","form_type":"4"}},{"id":2276587,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Common Stock","published_at":"2022-05-11T00:54:33.000Z","date":"2022-05-09","kind":"exercise","acquired":true,"shares":11560,"price":21.76,"value":251545.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 29, 2021."}],"balance_after":174459.3402,"source":{"system":"sec-edgar","filing":"0001225208-22-006814","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822006814/doc4.xml","form_type":"4"}},{"id":2276586,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Common Stock","published_at":"2022-05-11T00:54:33.000Z","date":"2022-05-08","kind":"tax_withholding","acquired":false,"shares":615,"price":100.52,"value":61819.8,"ownership":{"direct":true},"balance_after":162899.3402,"source":{"system":"sec-edgar","filing":"0001225208-22-006814","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822006814/doc4.xml","form_type":"4"}},{"id":2276585,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Common Stock","published_at":"2022-05-11T00:54:33.000Z","date":"2022-05-08","kind":"exercise","acquired":true,"shares":8531,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 8, 2019, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 2, 2022, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 8, 2022, and the actual number of shares vested are reflected on this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 8, 2019, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 2, 2022, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 8, 2022, and the actual number of shares vested are reflected on this Form 4."}],"balance_after":163514.3402,"source":{"system":"sec-edgar","filing":"0001225208-22-006814","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822006814/doc4.xml","form_type":"4"}},{"id":2276584,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Common Stock","published_at":"2022-05-11T00:54:33.000Z","date":"2022-05-07","kind":"tax_withholding","acquired":false,"shares":51,"price":100.52,"value":5126.52,"ownership":{"direct":true},"balance_after":154983.3402,"source":{"system":"sec-edgar","filing":"0001225208-22-006814","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822006814/doc4.xml","form_type":"4"}},{"id":2281148,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Performance Rights","published_at":"2022-05-05T21:50:27.000Z","date":"2022-05-03","kind":"grant","acquired":true,"shares":3425,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 3, 2022 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and scheduled to vest on May 3, 2025. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 3, 2022 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and scheduled to vest on May 3, 2025. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."}],"balance_after":3425,"derivative":{"exercise_date":"2025-05-03","underlying":"Common Stock","underlying_shares":3425},"source":{"system":"sec-edgar","filing":"0001225208-22-006579","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822006579/doc4.xml","form_type":"4"}},{"id":2281147,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2022-05-05T21:50:27.000Z","date":"2022-05-03","kind":"grant","acquired":true,"shares":24500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on May 3, 2022 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one month after the grant date in 36 approximately equal monthly installments."}],"balance_after":24500,"derivative":{"exercise_price":105.93,"exercise_date":"2023-05-03","expiration_date":"2029-05-02","underlying":"Common Stock","underlying_shares":24500},"source":{"system":"sec-edgar","filing":"0001225208-22-006579","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822006579/doc4.xml","form_type":"4"}},{"id":2281146,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Common Stock","published_at":"2022-05-05T21:50:27.000Z","date":"2022-05-04","kind":"tax_withholding","acquired":false,"shares":42,"price":105.93,"value":4449.06,"ownership":{"direct":true},"balance_after":155034.3402,"source":{"system":"sec-edgar","filing":"0001225208-22-006579","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822006579/doc4.xml","form_type":"4"}},{"id":2281145,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Common Stock","published_at":"2022-05-05T21:50:27.000Z","date":"2022-05-03","kind":"grant","acquired":true,"shares":2750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 3, 2022 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":155076.3402,"source":{"system":"sec-edgar","filing":"0001225208-22-006579","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822006579/doc4.xml","form_type":"4"}},{"id":2299584,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2022-04-11T23:03:18.000Z","date":"2022-04-08","kind":"exercise","acquired":false,"shares":11660,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11560,"derivative":{"exercise_price":21.76,"exercise_date":"2016-05-14","expiration_date":"2022-05-13","underlying":"Common Stock","underlying_shares":11660},"source":{"system":"sec-edgar","filing":"0001225208-22-005750","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822005750/doc4.xml","form_type":"4"}},{"id":2299583,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Common Stock","published_at":"2022-04-11T23:03:18.000Z","date":"2022-04-08","kind":"sale","acquired":false,"shares":11560,"price":123.2928,"value":1425264.768,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 29, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $122.57 to $123.55. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":152326.3402,"source":{"system":"sec-edgar","filing":"0001225208-22-005750","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822005750/doc4.xml","form_type":"4"}},{"id":2299582,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Common Stock","published_at":"2022-04-11T23:03:18.000Z","date":"2022-04-08","kind":"sale","acquired":false,"shares":100,"price":123.57,"value":12357.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 29, 2021."}],"balance_after":163886.3402,"source":{"system":"sec-edgar","filing":"0001225208-22-005750","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822005750/doc4.xml","form_type":"4"}},{"id":2299581,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Common Stock","published_at":"2022-04-11T23:03:18.000Z","date":"2022-04-08","kind":"exercise","acquired":true,"shares":11660,"price":21.76,"value":253721.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 29, 2021."}],"balance_after":163986.3402,"source":{"system":"sec-edgar","filing":"0001225208-22-005750","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822005750/doc4.xml","form_type":"4"}},{"id":2338295,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2022-03-12T00:01:58.000Z","date":"2022-03-11","kind":"exercise","acquired":false,"shares":11660,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":23220,"derivative":{"exercise_price":21.76,"exercise_date":"2016-05-14","expiration_date":"2022-05-13","underlying":"Common Stock","underlying_shares":11660},"source":{"system":"sec-edgar","filing":"0001225208-22-004574","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822004574/doc4.xml","form_type":"4"}},{"id":2338294,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Common Stock","published_at":"2022-03-12T00:01:58.000Z","date":"2022-03-11","kind":"sale","acquired":false,"shares":6535,"price":105.648,"value":690409.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 29, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $105.14 to $106.12. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":152103.487,"source":{"system":"sec-edgar","filing":"0001225208-22-004574","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822004574/doc4.xml","form_type":"4"}},{"id":2338293,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Common Stock","published_at":"2022-03-12T00:01:58.000Z","date":"2022-03-11","kind":"sale","acquired":false,"shares":5125,"price":106.4706,"value":545661.825,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 29, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $106.18 to $106.81. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":158638.487,"source":{"system":"sec-edgar","filing":"0001225208-22-004574","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822004574/doc4.xml","form_type":"4"}},{"id":2338292,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Common Stock","published_at":"2022-03-12T00:01:58.000Z","date":"2022-03-11","kind":"exercise","acquired":true,"shares":11660,"price":21.76,"value":253721.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 29, 2021."}],"balance_after":163763.487,"source":{"system":"sec-edgar","filing":"0001225208-22-004574","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822004574/doc4.xml","form_type":"4"}},{"id":2493640,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2021-11-30T01:21:52.000Z","date":"2021-11-29","kind":"exercise","acquired":false,"shares":100,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":34880,"derivative":{"exercise_price":21.76,"exercise_date":"2016-05-14","expiration_date":"2022-05-13","underlying":"Common Stock","underlying_shares":100},"source":{"system":"sec-edgar","filing":"0001225208-21-014184","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821014184/doc4.xml","form_type":"4"}},{"id":2493639,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Common Stock","published_at":"2021-11-30T01:21:52.000Z","date":"2021-11-29","kind":"sale","acquired":false,"shares":100,"price":110.58,"value":11058.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 29, 2021."}],"balance_after":152103.487,"source":{"system":"sec-edgar","filing":"0001225208-21-014184","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821014184/doc4.xml","form_type":"4"}},{"id":2493638,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Common Stock","published_at":"2021-11-30T01:21:52.000Z","date":"2021-11-29","kind":"exercise","acquired":true,"shares":100,"price":21.76,"value":2176.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 29, 2021."}],"balance_after":152203.487,"source":{"system":"sec-edgar","filing":"0001225208-21-014184","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821014184/doc4.xml","form_type":"4"}},{"id":2706202,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Performance Rights","published_at":"2021-05-19T20:31:27.000Z","date":"2021-05-17","kind":"exercise","acquired":false,"shares":10631,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On May 17, 2018, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period.  On May 3, 2021, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 17, 2021, and the actual number of shares vested are reflected on this Form 4."}],"balance_after":0,"derivative":{"exercise_date":"2021-05-17","expiration_date":"2025-05-16","underlying":"Common Stock","underlying_shares":10631},"source":{"system":"sec-edgar","filing":"0001225208-21-008307","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821008307/doc4.xml","form_type":"4"}},{"id":2706201,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Common Stock","published_at":"2021-05-19T20:31:27.000Z","date":"2021-05-17","kind":"tax_withholding","acquired":false,"shares":623,"price":89.49,"value":55752.27,"ownership":{"direct":true},"balance_after":152062.138,"source":{"system":"sec-edgar","filing":"0001225208-21-008307","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821008307/doc4.xml","form_type":"4"}},{"id":2706200,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Common Stock","published_at":"2021-05-19T20:31:27.000Z","date":"2021-05-17","kind":"tax_withholding","acquired":false,"shares":143,"price":89.49,"value":12797.07,"ownership":{"direct":true},"balance_after":152685.138,"source":{"system":"sec-edgar","filing":"0001225208-21-008307","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821008307/doc4.xml","form_type":"4"}},{"id":2706199,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Common Stock","published_at":"2021-05-19T20:31:27.000Z","date":"2021-05-17","kind":"exercise","acquired":true,"shares":10631,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 17, 2018, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period.  On May 3, 2021, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 17, 2021, and the actual number of shares vested are reflected on this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 17, 2018, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period.  On May 3, 2021, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 17, 2021, and the actual number of shares vested are reflected on this Form 4."}],"balance_after":152828.138,"source":{"system":"sec-edgar","filing":"0001225208-21-008307","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821008307/doc4.xml","form_type":"4"}},{"id":2717072,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Common Stock","published_at":"2021-05-13T01:38:36.000Z","date":"2021-05-11","kind":"tax_withholding","acquired":false,"shares":143,"price":90.4,"value":12927.2,"ownership":{"direct":true},"balance_after":142197.138,"source":{"system":"sec-edgar","filing":"0001225208-21-008063","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821008063/doc4.xml","form_type":"4"}},{"id":2719253,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Common Stock","published_at":"2021-05-11T14:03:26.000Z","date":"2021-05-07","kind":"tax_withholding","acquired":false,"shares":51,"price":91.75,"value":4679.25,"ownership":{"direct":true},"balance_after":142340.138,"source":{"system":"sec-edgar","filing":"0001225208-21-007900","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821007900/doc4.xml","form_type":"4"}},{"id":2725462,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Performance Rights","published_at":"2021-05-07T01:11:21.000Z","date":"2021-05-04","kind":"grant","acquired":true,"shares":3550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program on May 4, 2021 and scheduled to vest on May 4, 2024. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."}],"balance_after":3550,"derivative":{"exercise_date":"2024-05-04","expiration_date":"2028-05-03","underlying":"Common Stock","underlying_shares":3550},"source":{"system":"sec-edgar","filing":"0001225208-21-007708","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821007708/doc4.xml","form_type":"4"}},{"id":2725461,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2021-05-07T01:11:21.000Z","date":"2021-05-04","kind":"grant","acquired":true,"shares":27800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on May 4, 2021 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one month after the grant date in 36 approximately equal monthly installments."}],"balance_after":27800,"derivative":{"exercise_price":93.31,"exercise_date":"2022-05-04","expiration_date":"2028-05-03","underlying":"Common Stock","underlying_shares":27800},"source":{"system":"sec-edgar","filing":"0001225208-21-007708","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821007708/doc4.xml","form_type":"4"}},{"id":2725460,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Common Stock","published_at":"2021-05-07T01:11:21.000Z","date":"2021-05-04","kind":"grant","acquired":true,"shares":2850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 4, 2021 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":142391.138,"source":{"system":"sec-edgar","filing":"0001225208-21-007708","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821007708/doc4.xml","form_type":"4"}},{"id":2765019,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2021-04-01T23:11:12.000Z","date":"2021-04-01","kind":"exercise","acquired":false,"shares":13020,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":13.98,"exercise_date":"2015-05-08","expiration_date":"2021-05-07","underlying":"Common Stock","underlying_shares":13020},"source":{"system":"sec-edgar","filing":"0001225208-21-006242","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821006242/doc4.xml","form_type":"4"}},{"id":2765018,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Common Stock","published_at":"2021-04-01T23:11:12.000Z","date":"2021-04-01","kind":"sale","acquired":false,"shares":13020,"price":83.6608,"value":1089263.616,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 23, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $83.1600 to $84.0000. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":139541.138,"source":{"system":"sec-edgar","filing":"0001225208-21-006242","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821006242/doc4.xml","form_type":"4"}},{"id":2765017,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Common Stock","published_at":"2021-04-01T23:11:12.000Z","date":"2021-04-01","kind":"exercise","acquired":true,"shares":13020,"price":13.98,"value":182019.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 23, 2020."}],"balance_after":152561.138,"source":{"system":"sec-edgar","filing":"0001225208-21-006242","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821006242/doc4.xml","form_type":"4"}},{"id":2827489,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2021-03-02T01:15:47.000Z","date":"2021-03-01","kind":"exercise","acquired":false,"shares":13020,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13020,"derivative":{"exercise_price":13.98,"exercise_date":"2015-05-08","expiration_date":"2021-05-07","underlying":"Common Stock","underlying_shares":13020},"source":{"system":"sec-edgar","filing":"0001225208-21-004099","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821004099/doc4.xml","form_type":"4"}},{"id":2827488,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Common Stock","published_at":"2021-03-02T01:15:47.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":9592,"price":84.5798,"value":811289.4416,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 23, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $83.9900 to $84.9800. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":139220.7448,"source":{"system":"sec-edgar","filing":"0001225208-21-004099","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821004099/doc4.xml","form_type":"4"}},{"id":2827487,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Common Stock","published_at":"2021-03-02T01:15:47.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":3428,"price":85.1148,"value":291773.5344,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 23, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $84.9900 to $85.3050. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":148812.7448,"source":{"system":"sec-edgar","filing":"0001225208-21-004099","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821004099/doc4.xml","form_type":"4"}},{"id":2827486,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Common Stock","published_at":"2021-03-02T01:15:47.000Z","date":"2021-03-01","kind":"exercise","acquired":true,"shares":13020,"price":13.98,"value":182019.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 23, 2020."}],"balance_after":152240.7448,"source":{"system":"sec-edgar","filing":"0001225208-21-004099","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821004099/doc4.xml","form_type":"4"}},{"id":2889140,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2021-02-02T02:39:35.000Z","date":"2021-02-01","kind":"exercise","acquired":false,"shares":13020,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":26040,"derivative":{"exercise_price":13.98,"exercise_date":"2015-05-08","expiration_date":"2021-05-07","underlying":"Common Stock","underlying_shares":13020},"source":{"system":"sec-edgar","filing":"0001225208-21-001360","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821001360/doc4.xml","form_type":"4"}},{"id":2889139,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2021-02-02T02:39:35.000Z","date":"2021-02-01","kind":"exercise","acquired":false,"shares":7503,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":11.35,"exercise_date":"2015-02-20","expiration_date":"2021-02-19","underlying":"Common Stock","underlying_shares":7503},"source":{"system":"sec-edgar","filing":"0001225208-21-001360","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821001360/doc4.xml","form_type":"4"}},{"id":2889138,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Common Stock","published_at":"2021-02-02T02:39:35.000Z","date":"2021-02-01","kind":"sale","acquired":false,"shares":20523,"price":83.5057,"value":1713787.4811,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 23, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $83.1600 to $83.7100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":139220.7448,"source":{"system":"sec-edgar","filing":"0001225208-21-001360","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821001360/doc4.xml","form_type":"4"}},{"id":2889137,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Common Stock","published_at":"2021-02-02T02:39:35.000Z","date":"2021-02-01","kind":"exercise","acquired":true,"shares":7503,"price":11.35,"value":85159.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 23, 2020."}],"balance_after":159743.7448,"source":{"system":"sec-edgar","filing":"0001225208-21-001360","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821001360/doc4.xml","form_type":"4"}},{"id":2889136,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Common Stock","published_at":"2021-02-02T02:39:35.000Z","date":"2021-02-01","kind":"exercise","acquired":true,"shares":13020,"price":13.98,"value":182019.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 23, 2020."}],"balance_after":152240.7448,"source":{"system":"sec-edgar","filing":"0001225208-21-001360","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821001360/doc4.xml","form_type":"4"}},{"id":2926167,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2021-01-04T23:19:42.000Z","date":"2021-01-04","kind":"exercise","acquired":false,"shares":13020,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":39060,"derivative":{"exercise_price":13.98,"exercise_date":"2015-05-08","expiration_date":"2021-05-07","underlying":"Common Stock","underlying_shares":13020},"source":{"system":"sec-edgar","filing":"0001225208-21-000102","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821000102/doc4.xml","form_type":"4"}},{"id":2926166,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2021-01-04T23:19:42.000Z","date":"2021-01-04","kind":"exercise","acquired":false,"shares":7503,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7503,"derivative":{"exercise_price":11.35,"exercise_date":"2015-02-20","expiration_date":"2021-02-19","underlying":"Common Stock","underlying_shares":7503},"source":{"system":"sec-edgar","filing":"0001225208-21-000102","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821000102/doc4.xml","form_type":"4"}},{"id":2926165,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Common Stock","published_at":"2021-01-04T23:19:42.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":20523,"price":91.2379,"value":1872475.4217,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 23, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $90.6600 to $91.6200.  The price reported above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":139220.7448,"source":{"system":"sec-edgar","filing":"0001225208-21-000102","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821000102/doc4.xml","form_type":"4"}},{"id":2926164,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Common Stock","published_at":"2021-01-04T23:19:42.000Z","date":"2021-01-04","kind":"exercise","acquired":true,"shares":7503,"price":11.35,"value":85159.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 23, 2020."}],"balance_after":159743.7448,"source":{"system":"sec-edgar","filing":"0001225208-21-000102","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821000102/doc4.xml","form_type":"4"}},{"id":2926163,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Common Stock","published_at":"2021-01-04T23:19:42.000Z","date":"2021-01-04","kind":"exercise","acquired":true,"shares":13020,"price":13.98,"value":182019.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 23, 2020."}],"balance_after":152240.7448,"source":{"system":"sec-edgar","filing":"0001225208-21-000102","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821000102/doc4.xml","form_type":"4"}},{"id":3151357,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Performance Rights","published_at":"2020-05-13T20:11:41.000Z","date":"2020-05-11","kind":"exercise","acquired":false,"shares":3587,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On May 11, 2017, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2020, the Compensation Committee of the Board of Directors determined that 175% of the target shares would vest as of May 11, 2020, and the actual number of shares vested are reflected on this Form."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On May 11, 2017, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2020, the Compensation Committee of the Board of Directors determined that 175% of the target shares would vest as of May 11, 2020, and the actual number of shares vested are reflected on this Form."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On May 11, 2017, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2020, the Compensation Committee of the Board of Directors determined that 175% of the target shares would vest as of May 11, 2020, and the actual number of shares vested are reflected on this Form."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On May 11, 2017, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2020, the Compensation Committee of the Board of Directors determined that 175% of the target shares would vest as of May 11, 2020, and the actual number of shares vested are reflected on this Form."}],"balance_after":0,"derivative":{"exercise_date":"2020-05-11","underlying":"Common Stock","underlying_shares":3587},"source":{"system":"sec-edgar","filing":"0001225208-20-007573","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520820007573/doc4.xml","form_type":"4"}},{"id":3151356,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Common Stock","published_at":"2020-05-13T20:11:41.000Z","date":"2020-05-12","kind":"tax_withholding","acquired":false,"shares":25,"price":225.05,"value":5626.25,"ownership":{"direct":true},"balance_after":46385.0477,"source":{"system":"sec-edgar","filing":"0001225208-20-007573","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520820007573/doc4.xml","form_type":"4"}},{"id":3151355,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Common Stock","published_at":"2020-05-13T20:11:41.000Z","date":"2020-05-11","kind":"tax_withholding","acquired":false,"shares":210,"price":217.84,"value":45746.4,"ownership":{"direct":true},"balance_after":46410.0477,"source":{"system":"sec-edgar","filing":"0001225208-20-007573","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520820007573/doc4.xml","form_type":"4"}},{"id":3151354,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Common Stock","published_at":"2020-05-13T20:11:41.000Z","date":"2020-05-11","kind":"tax_withholding","acquired":false,"shares":48,"price":217.84,"value":10456.32,"ownership":{"direct":true},"balance_after":46620.0477,"source":{"system":"sec-edgar","filing":"0001225208-20-007573","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520820007573/doc4.xml","form_type":"4"}},{"id":3151353,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Common Stock","published_at":"2020-05-13T20:11:41.000Z","date":"2020-05-11","kind":"exercise","acquired":true,"shares":3587,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 11, 2017, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2020, the Compensation Committee of the Board of Directors determined that 175% of the target shares would vest as of May 11, 2020, and the actual number of shares vested are reflected on this Form."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 11, 2017, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2020, the Compensation Committee of the Board of Directors determined that 175% of the target shares would vest as of May 11, 2020, and the actual number of shares vested are reflected on this Form."}],"balance_after":46668.0477,"source":{"system":"sec-edgar","filing":"0001225208-20-007573","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520820007573/doc4.xml","form_type":"4"}},{"id":3156933,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Performance Rights","published_at":"2020-05-08T23:33:10.000Z","date":"2020-05-07","kind":"grant","acquired":true,"shares":1425,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program on May 7, 2020 and scheduled to vest on May 7, 2023. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."},{"field":"shares","element":"transactionShares","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program on May 7, 2020 and scheduled to vest on May 7, 2023. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program on May 7, 2020 and scheduled to vest on May 7, 2023. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program on May 7, 2020 and scheduled to vest on May 7, 2023. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program on May 7, 2020 and scheduled to vest on May 7, 2023. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."}],"balance_after":1425,"derivative":{"exercise_date":"2023-05-07","expiration_date":"2027-05-06","underlying":"Common Stock","underlying_shares":1425},"source":{"system":"sec-edgar","filing":"0001225208-20-007342","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520820007342/doc4.xml","form_type":"4"}},{"id":3156932,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":89142,"kind":"person","name":"Lemercier Jean-Luc M","position":1,"cik":"0001710625","reported_name":"Lemercier Jean-Luc M","relationship":{"officer":true,"officer_title":"CVP, EMEA, Canada, Latin Amer"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2020-05-08T23:33:10.000Z","date":"2020-05-07","kind":"grant","acquired":true,"shares":11500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on May 7, 2020 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one month after the grant date in 36 approximately equal monthly installments."}],"balance_after":11500,"derivative":{"exercise_price":218.04,"exercise_date":"2020-06-07","expiration_date":"2027-05-06","underlying":"Common Stock","underlying_shares":11500},"source":{"system":"sec-edgar","filing":"0001225208-20-007342","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520820007342/doc4.xml","form_type":"4"}}],"next_cursor":"2020-05-08T23:33:10.000000Z,3156932"}